In the West, the authorities prohibit all new drugs for weight loss. Last week in the UK with sales of Reductil was withdrawn, and this was the turn of rimonabant. Maybe a really effective and safe for the health diet pills do not exist?
Experts point out that Rimonabant there are serious side effects . It can cause depression and other mental disorders. A number of the victims of its application the British (among them people who lost because of depression works) preparing a lawsuit against the manufacturer of the drug of the French company Sanofi-Aventis.
As for Reductil Then it was removed from the market, as the experts have identified serious risks to the cardiovascular system, which arise after his regular admission. Thus, the latest obesity drug licensed in the UK remained " Xenical "And the weaker, non-prescription drug" Allan ". They accelerate the process of passing fat through the digestive tract before he has time to digest fat. Unfortunately, these diet pills beat and "good" fats Omega-3, as well as for fat dissolving vitamins D and E. Another unpleasant side effect It is diarrhea.
Well, you say, we are ready to go even through diarrhea and loss of omega-3, if these drugs really help to lose weight. Really helps. After a year of receiving " Allaya "You can expect to lose as much as 5 kg! So Worth It?
The whole history of the development and introduction of drugs for weight loss is some kind of chronicle of horrors. Tablets penetrated the market, causing dependence in patients, fever, chronic insomnia, mood swings, and even blindness. And then banned. After the incident with Rimonabant just 27 new medicines from excess weight, ready for clinical trials, have been banned. Maybe we just do not count on the "miraculous" diet pills - They do not exist and never will.
What is? One of the most effective methods to combat obesity is surgery on the stomach. It is indicated for people suffering from morbid obesity. Everyone else should stick to a diet and exercise!
Diets
Go back to the main page
Немає коментарів:
Дописати коментар